デフォルト表紙
市場調査レポート
商品コード
1619195

コンパニオンアニマル向け医療の市場規模・シェア・成長分析 (製品種類別、動物の種類別、エンドユーザー別、流通チャネル別、地域別):産業予測 (2024~2031年)

Companion Animal Healthcare Market Size, Share, Growth Analysis, By Product Type (Pharmaceuticals, Vaccines), By Animal Type (Dogs, Cats), By End User, By Distribution Channel, By Region - Industry Forecast 2024-2031


出版日
発行
SkyQuest
ページ情報
英文 157 Pages
納期
3~5営業日
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=150.06円
コンパニオンアニマル向け医療の市場規模・シェア・成長分析 (製品種類別、動物の種類別、エンドユーザー別、流通チャネル別、地域別):産業予測 (2024~2031年)
出版日: 2024年12月20日
発行: SkyQuest
ページ情報: 英文 157 Pages
納期: 3~5営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

世界のコンパニオンアニマル向け医療の市場規模は、2022年に216億米ドルと評価され、2023年の235億7,000万米ドルから2031年には473億米ドルに成長し、予測期間中 (2024-2031年) のCAGRは9.1%で成長する見通しです。

リモートワークの急増に伴い、孤独感や不安感を和らげるため、ペットを飼う人々が増えています。欧州ペットフード産業報告書によると、欧州では2022年に約3億4,000万匹のコンパニオンアニマルが飼育され、46%の世帯が少なくとも1匹のペットを飼っています。特にドイツでは、犬が約1,060万匹、猫が約1,520万匹と報告されており、猫の飼育率が高いことがわかる。同時に、ペットの健康問題、特に犬のがん罹患率の増加は、獣医療強化の必要性を強調しています。英国王立獣医科大学の2023年6月の調査では、英国の犬種における重大ながんリスクが浮き彫りになりました。ペットケアに対する需要の高まりに対応するため、企業は市場でのプレゼンスを拡大しつつあります。2023年11月にInspire Veterinary PartnersがValley Veterinary Service Inc.を買収し、高度なペット医療施設へのアクセスを強化したことがその証左です。

目次

イントロダクション

  • 分析目的
  • 市場範囲
  • 定義

分析手法

  • 情報調達
  • 二次・一次データの手法
  • 市場規模予測
  • 市場の想定と制約

エグゼクティブサマリー

  • 市場の概要と展望
  • 需給動向の分析
  • セグメント別の機会分析

市場力学と展望

  • 市場概要
  • 市場規模
  • 市場力学
    • 促進要因と機会
    • 抑制要因と課題
  • ポーター分析と影響
    • 競争企業間の敵対関係
    • 代替品の脅威
    • 買い手の交渉力
    • 新規参入業者の脅威
    • 供給企業の交渉力

市場の主な考察

  • 主な成功要因
  • 競合の程度
  • 主な投資財源
  • 市場エコシステム
  • 市場魅力度指数 (2023年)
  • PESTEL分析
  • マクロ経済指標
  • バリューチェーン分析
  • 価格分析
  • 技術進歩
  • 規制情勢
  • 特許分析
  • ケーススタディ

世界のコンパニオンアニマル向け医療の市場規模・CAGR:製品種類別 (2024~2031年)

  • 市場概要
  • 医薬品
    • 抗生物質
    • 抗炎症薬
    • 寄生虫駆除剤
    • 疼痛管理
    • その他
  • ワクチン
    • 生弱毒化ワクチン
    • 不活化ワクチン
    • 組み換えワクチン
    • その他
  • 診断
    • 免疫診断検査
    • 分子診断
    • 診断画像
    • 臨床化学
    • その他
  • 飼料添加物
    • 栄養飼料添加物
    • 医薬品飼料添加物

世界のコンパニオンアニマル向け医療の市場規模・CAGR:動物の種類別 (2024~2031年)

  • 市場概要
  • その他

世界のコンパニオンアニマル向け医療の市場規模・CAGR:エンドユーザー別 (2024~2031年)

  • 市場概要
  • 動物病院・クリニック
  • 診断検査室
  • 研究機関
  • 在宅医療

世界のコンパニオンアニマル向け医療の市場規模・CAGR:流通チャネル別 (2024~2031年)

  • 市場概要
  • 病院薬局
  • 小売薬局
  • オンライン薬局

世界のコンパニオンアニマル向け医療の市場規模・CAGR (2024~2031年)

  • 北米
    • 米国
    • カナダ
  • 欧州
    • 英国
    • ドイツ
    • スペイン
    • フランス
    • イタリア
    • その他欧州地域
  • アジア太平洋
    • 中国
    • インド
    • 日本
    • 韓国
    • その他アジア太平洋地域
  • ラテンアメリカ
    • ブラジル
    • その他ラテンアメリカ地域
  • 中東・アフリカ
    • GCC諸国
    • 南アフリカ
    • その他中東・アフリカ

競合情勢

  • 上位5社の比較
  • 主要企業の市場ポジショニング(2023年)
  • 主要企業が採用した戦略
  • 市場の近年の動向
  • 主要企業の市場シェア(2023年)
  • 主要企業のプロファイル
    • 企業概要
    • 製品ポートフォリオ分析
    • セグメント別シェア分析
    • 収益の前年比比較 (2021~2023年)

主要企業プロファイル

  • Zoetis Inc.
  • Merck & Co., Inc.
  • Boehringer Ingelheim International GmbH
  • Elanco Animal Health Incorporated
  • Bayer AG
  • Ceva Sante Animale
  • Virbac
  • Vetoquinol S.A.
  • Heska Corporation
  • IDEXX Laboratories, Inc.
  • Dechra Pharmaceuticals PLC
  • Phibro Animal Health Corporation
  • Ourofino Saude Animal
  • Neogen Corporation
  • Ceva Animal Health LLC

結論と推奨事項

目次
Product Code: SQMIG35E2026

Global Companion Animal Healthcare Market size was valued at USD 21.60 billion in 2022 and is poised to grow from USD 23.57 billion in 2023 to USD 47.30 billion by 2031, growing at a CAGR of 9.1% during the forecast period (2024-2031).

The surge in remote work has catalyzed pet adoption, as individuals seek companionship to alleviate feelings of isolation and anxiety. According to the European Pet Food Industry report, Europe housed approximately 340 million companion animals in 2022, with 46% of households owning at least one pet. Notably, Germany reported around 10.6 million dogs and 15.2 million cats, indicating a higher adoption rate for cats. Concurrently, the rise in pet health concerns, particularly the increasing incidence of cancer in dogs, underscores the need for enhanced veterinary care. The Royal Veterinary College's June 2023 study highlighted significant cancer risks in UK dog breeds. To capitalize on the growing demand for pet care, companies are expanding their market presence, as evidenced by Inspire Veterinary Partners' acquisition of Valley Veterinary Service Inc. in November 2023, enhancing access to advanced pet healthcare facilities.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Companion Animal Healthcare market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Companion Animal Healthcare Market Segmental Analysis

Global Companion Animal Healthcare Market is segmented by product type, animal type, end user, distribution channel and region. Based on product type, the market is segmented into pharmaceuticals (antibiotics, anti-inflammatory drugs, parasiticides, pain management, others), vaccines (live attenuated vaccines, inactivated vaccines, recombinant vaccines, others), diagnostics (immunodiagnostic tests, molecular diagnostics, diagnostic imaging, clinical chemistry, others) and feed additives (nutritional feed additives, medicinal feed additives). Based on animal type, the market is segmented into dogs, cats, horses and other. Based on end user, the market is segmented into veterinary hospitals & clinics, diagnostic laboratories, research institutes and home care settings. Based on distribution channel, the market is segmented into Hospital Pharmacies, retail pharmacies and online pharmacies. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Companion Animal Healthcare Market

The global companion animal healthcare market is significantly driven by the rising trend of pet ownership worldwide. As more individuals embrace pets as companions, there is a corresponding surge in the demand for various health services, including veterinary care, vaccinations, and wellness products tailored for animals. This growth in pet ownership can be attributed to several factors, such as urban living conditions, evolving lifestyles, and heightened awareness of the numerous benefits associated with having pets. Ultimately, as more people bring pets into their homes, the need for comprehensive healthcare solutions for these animals continues to expand, fueling market growth.

Restraints in the Global Companion Animal Healthcare Market

One of the significant constraints in the Global Companion Animal Healthcare market is the rising cost of veterinary care. The expense associated with advanced treatments and procedures can be prohibitively high, impeding pet owners from accessing the full spectrum of healthcare options for their animals. This financial hurdle disproportionately affects low- and moderate-income pet owners, who may struggle to provide necessary medical care for their pets. As a result, the lack of affordability can lead to an inadequate healthcare experience, failing to meet the comprehensive needs of companion animals and limiting their overall health and well-being.

Market Trends of the Global Companion Animal Healthcare Market

The Global Companion Animal Healthcare market is witnessing a notable trend towards the increasing adoption of pet insurance, driven by a growing awareness among pet owners about the financial benefits of such coverage. As veterinary costs continue to rise, pet insurance provides a viable solution for managing expenses related to medical, surgical, and preventative care, alleviating financial stress for pet owners. This shift is further fueled by a heightened emphasis on the well-being of pets, prompting owners to seek comprehensive healthcare solutions. Consequently, this surge in pet insurance adoption is expected to significantly contribute to market growth and shape future healthcare strategies for companion animals.

Table of Contents

Introduction

  • Objectives of the Study
  • Scope of the Report
  • Definitions

Research Methodology

  • Information Procurement
  • Secondary & Primary Data Methods
  • Market Size Estimation
  • Market Assumptions & Limitations

Executive Summary

  • Global Market Outlook
  • Supply & Demand Trend Analysis
  • Segmental Opportunity Analysis

Market Dynamics & Outlook

  • Market Overview
  • Market Size
  • Market Dynamics
    • Driver & Opportunities
    • Restraints & Challenges
  • Porters Analysis & Impact
    • Competitive rivalry
    • Threat of substitute
    • Bargaining power of buyers
    • Threat of new entrants
    • Bargaining power of suppliers

Key Market Insights

  • Key Success Factors
  • Degree of Competition
  • Top Investment Pockets
  • Market Ecosystem
  • Market Attractiveness Index, 2023
  • PESTEL Analysis
  • Macro-Economic Indicators
  • Value Chain Analysis
  • Pricing Analysis
  • Regulatory Landscape
  • Patent Analysis
  • Case Studies

Global Companion Animal Healthcare Market Size by Product Type & CAGR (2024-2031)

  • Market Overview
  • Pharmaceuticals
    • Antibiotics
    • Anti-inflammatory Drugs
    • Parasiticides
    • Pain Management
    • Others
  • Vaccines
    • Live Attenuated Vaccines
    • Inactivated Vaccines
    • Recombinant Vaccines
    • Others
  • Diagnostics
    • Immunodiagnostic Tests
    • Molecular Diagnostics
    • Diagnostic Imaging
    • Clinical Chemistry
    • Others
  • Feed Additives
    • Nutritional Feed Additives
    • Medicinal Feed Additives

Global Companion Animal Healthcare Market Size by Animal Type & CAGR (2024-2031)

  • Market Overview
  • Dogs
  • Cats
  • Horses
  • Other

Global Companion Animal Healthcare Market Size by End User & CAGR (2024-2031)

  • Market Overview
  • Veterinary Hospitals & Clinics
  • Diagnostic Laboratories
  • Research Institutes
  • Home Care Settings

Global Companion Animal Healthcare Market Size by Distribution Channel & CAGR (2024-2031)

  • Market Overview
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies

Global Companion Animal Healthcare Market Size & CAGR (2024-2031)

  • North America (Product Type, Animal Type, End User, Distribution Channel, Distribution Channel)
    • US
    • Canada
  • Europe (Product Type, Animal Type, End User, Distribution Channel)
    • UK
    • Germany
    • Spain
    • France
    • Italy
    • Rest of Europe
  • Asia-Pacific (Product Type, Animal Type, End User, Distribution Channel)
    • China
    • India
    • Japan
    • South Korea
    • Rest of Asia Pacific
  • Latin America (Product Type, Animal Type, End User, Distribution Channel)
    • Brazil
    • Rest of Latin America
  • Middle East & Africa (Product Type, Animal Type, End User, Distribution Channel)
    • GCC Countries
    • South Africa
    • Rest of Middle East & Africa

Competitive Intelligence

  • Top 5 Player Comparison
  • Market Positioning of Key Players, 2023
  • Strategies Adopted by Key Market Players
  • Recent Developments in the Market
  • Company Market Share Analysis, 2023
  • Company Profiles of All Key Players
    • Company Details
    • Product Portfolio Analysis
    • Company's Segmental Share Analysis
    • Revenue Y-O-Y Comparison (2021-2023)

Key Company Profiles

  • Zoetis Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Merck & Co., Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Boehringer Ingelheim International GmbH
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Elanco Animal Health Incorporated
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Bayer AG
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Ceva Sante Animale
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Virbac
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Vetoquinol S.A.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Heska Corporation
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • IDEXX Laboratories, Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Dechra Pharmaceuticals PLC
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Phibro Animal Health Corporation
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Ourofino Saude Animal
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Neogen Corporation
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Ceva Animal Health LLC
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments

Conclusion & Recommendation